Calendrier des promotions Anebulo Pharmaceuticals, Inc.
Calendrier avancé
Graphique simple
À propos de l'entreprise Anebulo Pharmaceuticals, Inc.
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist, which is in a Phase II clinical trial to address the unmet medical need for a specific antidote for ACI. The company was incorporated in 2020 and is based in Lakeway, Texas.| IPO date | 2021-05-07 |
|---|---|
| ISIN | US0345691036 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.anebulo.com |
| Цена ао | 1.55 |
| Changement de prix par jour: | +3.16% (0.95) |
|---|---|
| Changement de prix par semaine: | 0% (0.98) |
| Changement de prix par mois: | -42.69% (1.71) |
| Changement de prix sur 3 mois: | -38.58% (1.5955) |
| Changement de prix sur six mois: | -48.15% (1.89) |
| Changement de prix par an: | -66.88% (2.959) |
| Evolution du prix sur 3 ans: | -82.96% (5.75) |
| Evolution des prix depuis le début de l'année: | -1.01% (0.99) |
|
|
Sous-estimation
|
Efficacité
|
|||||||||||||||||||||||||||||||||||||
Dividendes
|
Devoir
|
Impulsion de croissance
|
|||||||||||||||||||||||||||||||||||||
| Établissements | Volume | Partager, % |
|---|---|---|
| 22NW, LP | 5366290 | 20.93 |
| Nantahala Capital Management, LLC | 1022146 | 3.99 |
| LVW Advisors, LLC | 643039 | 2.51 |
| Morgan Stanley | 399219 | 1.56 |
| Ikarian Capital, LLC | 157862 | 0.62 |
| Vanguard Group Inc | 153003 | 0.6 |
| BOOTHBAY FUND MANAGEMENT, LLC | 18978 | 0.07 |
| Landscape Capital Management LLC | 15000 | 0.06 |
| Tower Research Capital LLC (TRC) | 9102 | 0.04 |
| Blackrock Inc. | 4145 | 0.02 |
| Superviseur | Titre d'emploi | Paiement | Année de naissance |
|---|---|---|---|
| Dr. Joseph F. Lawler M.D., Ph.D. | Founder & Chairman | 11k | 1972 (53 année) |
| Dr. Kenneth C. Cundy Ph.D. | Chief Scientific Officer | 425.15k | 1959 (66 années) |
| Mr. Richard Anthony Cunningham | CEO & Director | N/A | 1971 (54 année) |
| Mr. Daniel V. George | Principal Accounting Officer, Acting CFO & Secretary | N/A | 1970 (55 années) |
Adresse: United States, Lakeway. TX, 1017 Ranch Road 620 South - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.anebulo.com
Site web: https://www.anebulo.com
